Medicine recalls
|
| |
| Canada: Recall: RIVA-FLUOXETINE: Affected lots exceed the interim acceptable intake limit for N-nitroso-fluoxetine |
| |
Health Canada announces that Laboratoire Riva Inc. is recalling 5 lots of RIVA-FLUOXETINE 10mg Capsule (lot number: D1196, D1513, D1831, D2026, D2610) from retailers because the affected lots exceed the interim acceptable intake limit for N-nitroso-fluoxetine.
RIVA-FLUOXETINE is indicated for depression, bulimia nervosa and obsessive-compulsive disorder.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/riva-fluoxetine-affected-lots-exceed-interim-acceptable-intake-limit-n-nitroso
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Wednesday, Apr 30, 2025
Issued at HKT 17:45
|
| |
